Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA Mont-Saint-Guibert (Belgium), July 1, 2024, […]
Mesoblast to File Biologics License Application for Ryoncil® FDA Approval Next Week
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory […]
Bukit Jalil Global Acquisition 1 Ltd. Adjourned the Extraordinary General Meeting to June 29, 2024
New York, NY, June 28, 2024 (GLOBE NEWSWIRE) — Bukit Jalil Global Acquisition 1 Ltd. (“BUJA” or the “Company”) (NASDAQ: […]
Oak Woods Acquisition Corporation Announces Extension of Completion Window to September 28, 2024
June 28, 2024 21:00 ET | Source: Oakwoods Acquisition New York, June 28, 2024 (GLOBE NEWSWIRE) — Oak Woods Acquisition Corporation (the […]
Bukit Jalil Global Acquisition 1 Ltd. Announces Increased Monthly Extension Fee in Connection with Proposed Charter Amendment
New York, NY, June 28, 2024 (GLOBE NEWSWIRE) — Bukit Jalil Global Acquisition 1 Ltd. (“BUJA” or the “Company”) (NASDAQ: […]
Critical Metals Corp. Joins Russell 2000®, Russell 3000® and Russell Microcap® Indexes
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) — Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp”), a leading mining development […]
Aimfinity Investment Corp. I Announces Extension of the Deadline for an Initial Business Combination to July 28, 2024
Wilmington, Delaware, June 28, 2024 (GLOBE NEWSWIRE) — Aimfinity Investment Corp. I (the “Company” or “AIMA”) (Nasdaq: AIMAU), a special […]
Record Notional Value of Shares Traded on the Nasdaq Closing Cross During the 2024 Russell US Indexes Reconstitution
Nasdaq Closing Cross continues to play an integral and innovative role in capital markets Global growth in trading volumes demands […]
Bilibili Inc. Announces Results of Annual General Meeting
SHANGHAI, China, June 28, 2024 (GLOBE NEWSWIRE) — Bilibili Inc. (Nasdaq: BILI and HKEX: 9626), an iconic brand and a […]
Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024
BETHESDA, Md., June 28, 2024 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology […]
